Eaton Vance Management decreased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 14.0% during the third quarter, Holdings Channel reports. The fund owned 770,700 shares of the company’s stock after selling 125,960 shares during the period. Eaton Vance Management owned approximately 0.24% of Agilent Technologies worth $36,292,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of the stock. ClariVest Asset Management LLC purchased a new position in Agilent Technologies during the second quarter valued at about $105,000. Penserra Capital Management LLC raised its position in Agilent Technologies by 100.0% in the third quarter. Penserra Capital Management LLC now owns 2,736 shares of the company’s stock valued at $128,000 after buying an additional 1,368 shares in the last quarter. Advisor Group Inc. raised its position in Agilent Technologies by 42.7% in the third quarter. Advisor Group Inc. now owns 2,812 shares of the company’s stock valued at $130,000 after buying an additional 841 shares in the last quarter. Catalyst Capital Advisors LLC purchased a new position in Agilent Technologies during the third quarter valued at about $183,000. Finally, FTB Advisors Inc. raised its position in Agilent Technologies by 817.2% in the third quarter. FTB Advisors Inc. now owns 4,265 shares of the company’s stock valued at $200,000 after buying an additional 3,800 shares in the last quarter.
Shares of Agilent Technologies, Inc. (NYSE:A) traded up 0.58% on Wednesday, hitting $49.93. 2,107,079 shares of the company’s stock were exchanged. The company’s 50-day moving average price is $47.80 and its 200 day moving average price is $46.47. Agilent Technologies, Inc. has a 12-month low of $34.75 and a 12-month high of $50.03. The stock has a market cap of $16.06 billion, a price-to-earnings ratio of 35.66 and a beta of 1.19.
Agilent Technologies (NYSE:A) last posted its earnings results on Tuesday, November 15th. The company reported $0.59 EPS for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.07. The firm had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.07 billion. Agilent Technologies had a net margin of 10.99% and a return on equity of 15.49%. The company’s revenue was up 7.3% on a year-over-year basis. During the same period last year, the firm posted $0.50 EPS. On average, equities analysts predict that Agilent Technologies, Inc. will post $2.13 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, January 25th. Investors of record on Tuesday, January 3rd were given a $0.132 dividend. This represents a $0.53 dividend on an annualized basis and a dividend yield of 1.06%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.12. The ex-dividend date was Thursday, December 29th. Agilent Technologies’s dividend payout ratio (DPR) is 37.59%.
Several research firms have issued reports on A. BTIG Research reaffirmed a “buy” rating and issued a $55.00 price target on shares of Agilent Technologies in a report on Sunday, December 4th. Zacks Investment Research raised shares of Agilent Technologies from a “sell” rating to a “hold” rating in a report on Thursday, November 17th. Barclays PLC raised shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $48.00 to $51.00 in a report on Wednesday, January 4th. Leerink Swann started coverage on shares of Agilent Technologies in a research note on Thursday, November 10th. They set an “outperform” rating and a $53.00 price objective for the company. Finally, Janney Montgomery Scott reiterated a “buy” rating on shares of Agilent Technologies in a research note on Friday, December 23rd. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $51.35.
In other Agilent Technologies news, insider Mark Doak sold 3,969 shares of the firm’s stock in a transaction on Friday, December 9th. The shares were sold at an average price of $46.00, for a total transaction of $182,574.00. Following the transaction, the insider now directly owns 54,626 shares of the company’s stock, valued at approximately $2,512,796. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Didier Hirsch sold 22,256 shares of the firm’s stock in a transaction on Wednesday, February 1st. The stock was sold at an average price of $49.50, for a total transaction of $1,101,672.00. The disclosure for this sale can be found here. Insiders sold a total of 53,185 shares of company stock worth $2,576,800 over the last ninety days.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).